7th Mar 2008 08:33
Midas Capital PLC07 March 2008 7 March 2008 MIDAS CAPITAL plc (the "COMPANY") Admission of Equity Following the successful completion of the acquisition by the Company of theentire issued share capital of Midas Capital Partners Limited, the Companyannounces the admission, in aggregate, of 57,324,170 ordinary shares of 10p each("Ordinary Shares") (being the re-admission of 22,824,041 existing OrdinaryShares, the admission of 27,500,129 new Ordinary Shares issued pursuant to theacquisition and the admission of 7,000,000 new Ordinary Shares issued pursuantto the placing to raise £10.5 million, before expenses) to trading on AIM todayunder the Company's new ticker symbol, 'MDS'. The ISIN for the Ordinary Sharescontinues to be GB00B01WR582. Michael Phillips, chief executive of Midas Capital plc, commented: "We are excited at the successful completion of this transaction and lookforward to building the Company into a leading multi-asset fund managementcompany operating in the UK." Simon Edwards, managing director of Midas Capital plc (and formerly chiefexecutive of Midas Capital Partners Limited), commented: "The merger with iimia MitonOptimal represents a new chapter in our history andprovides an infrastructure which will enable a very strong investment team tofocus on achieving good investment performance for clients. We look forward toworking closely with Mike Phillips and his team." EnquiriesMichael Phillips, Chief Executive, Midas Capital plc Tel: 07738 181 520Simon Edwards, Managing Director, Midas Capital plc Tel: 07947 118 670Sue Inglis, Intelli Corporate Finance Limited Tel: 020 7653 6300James Steel, Arbuthnot Securities Limited Tel: 020 7012 2000Roland Cross, Broadgate Tel: 020 7726 6111 Notes Unless the context otherwise requires, terms used in this announcement shallbear the meanings given to them in the Company's AIM admission document dated 12February 2008. Intelli, which is authorised and regulated by the FSA, is acting solely for theCompany and no one else in connection with the Proposals and will not beresponsible to anyone other than the Company for providing the regulatory andlegal protections afforded to customers (as defined by the FSA Rules) of Intellior for providing advice in relation to the contents of this document or anymatter, transaction or arrangement referred to in it. Arbuthnot, which is authorised and regulated by the FSA, is acting as nominatedadviser and broker to the Company and no one else in connection with Admissionand will not be responsible to any person other than the Company for providingthe regulatory and legal protections afforded to customers (as defined by theFSA Rules) of Arbuthnot or for providing advice in relation to the contents ofthis document or any matter, transaction or arrangement referred to in it. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
MGR.L